These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10500653)

  • 41. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation.
    Langrehr JM; Lohmann R; Guckelberger O; Müller AR; Raakow R; Nüssler NC; Klupp J; Pfitzmann R; Jonas S; Settmacher U; Steinmüller T; Neuhaus P
    Transplant Proc; 2001; 33(1-2):1433-4. PubMed ID: 11267360
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of immunosuppression on patient outcome after liver transplantation.
    Mueller AR; Platz KP; Willimski C; Berg T; Neuhaus R; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1495-6. PubMed ID: 9636608
    [No Abstract]   [Full Text] [Related]  

  • 45. Incidence of late acute rejection and progression to chronic rejection in pediatric liver recipients.
    Sellers M; Singer A; Maller E; Olthoff K; Jacobowski D; Shaked A
    Transplant Proc; 1997; 29(1-2):428-9. PubMed ID: 9123065
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of tacrolimus in renal transplantation.
    van Hooff JP; Christiaans MH
    Transplant Proc; 1999 Dec; 31(8):3298-9. PubMed ID: 10616483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?
    Groetzner J; Meiser BM; Schirmer J; Koglin J; vScheidt W; Klauss V; Cremer P; Reichenspurner H; Reichart B
    Transplant Proc; 2001; 33(1-2):1461-4. PubMed ID: 11267373
    [No Abstract]   [Full Text] [Related]  

  • 48. Reduced acute rejection and side effects with neoral in liver transplantation.
    Tisone G; Vennarecci G; Pisani F; Baiocchi L; Mercadante E; Orlando G; Anselmo A; Casciani CU
    Transplant Proc; 1998 Jun; 30(4):1430-1. PubMed ID: 9636579
    [No Abstract]   [Full Text] [Related]  

  • 49. Successful use of tacrolimus for initial rejection episodes after liver transplantation.
    Millis JM; Cronin DC; Newell KA; Bruce DS; Woodle ES; Grewal HP; Loss GE; Lissoos T; Conjeevaram H; Schiano T; O'Laughlin R; Charette J; McNaughton M; Baker AL; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1407-8. PubMed ID: 9636569
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
    Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basiliximab reduces acute liver allograft rejection in pediatric patients.
    Strassburg A; Pfister ED; Arning A; Nashan B; Ehrich JH; Melter M
    Transplant Proc; 2002 Sep; 34(6):2374-5. PubMed ID: 12270443
    [No Abstract]   [Full Text] [Related]  

  • 52. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
    Alghamdi S; Nabi Z; Skolnik E; Alkorbi L; Albaqumi M
    Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 54. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

  • 55. Tacrolimus (FK 506) in kidney transplantation.
    Vanrenterghem Y
    Transplant Proc; 1998 Aug; 30(5):2171-3. PubMed ID: 9723431
    [No Abstract]   [Full Text] [Related]  

  • 56. Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation.
    Doria C; Jain AK; Scott VL; Gruttadauria S; Marino IR; Doyle HR; Fung JJ
    Exp Clin Transplant; 2003 Jun; 1(1):48-55. PubMed ID: 15859907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tacrolimus: immunosuppression following liver and kidney transplant.
    Clark W
    J Clin Pharm Ther; 1996 Jun; 21(3):135-41. PubMed ID: 8873845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA; Gimson AE; Gibbs P; Alexander GJ
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.
    Mueller AR; Platz KP; Blumhardt G; Bechstein WO; Steinmüller T; Christe W; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1117-20. PubMed ID: 7533359
    [No Abstract]   [Full Text] [Related]  

  • 60. Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis.
    Hilgard P; Kahraman A; Lehmann N; Seltmann C; Beckebaum S; Ross RS; Baba HA; Malago M; Broelsch CE; Gerken G
    World J Gastroenterol; 2006 Feb; 12(5):697-702. PubMed ID: 16521181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.